Evidence map›Paper›PMID 38001619›Full record

ArticleCancers2023

Impact of the COVID-19 Pandemic on Staging Oncologic PET/CT Imaging and Patient Outcome in a Public Healthcare Context: Overview and Follow Up of the First Two Years of the Pandemic.

Andres Kohan, Sumesh Menon, Vanessa Murad, Seyed Ali Mirshahvalad, Roshini Kulanthaivelu, Adam Farag, Claudia Ortega, Ur Metser, Patrick Veit-Haibach

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Andres KohanToronto Joint Department Medical Imaging, University Health Network, Sinai Health System, Women's College Hospital, University Medical Imaging Toronto, Toronto, ON M5T 1W7, Canada.ORCID 0000-0003-3592-3000
Sumesh MenonToronto Joint Department Medical Imaging, University Health Network, Sinai Health System, Women's College Hospital, University Medical Imaging Toronto, Toronto, ON M5T 1W7, Canada.
Vanessa MuradToronto Joint Department Medical Imaging, University Health Network, Sinai Health System, Women's College Hospital, University Medical Imaging Toronto, Toronto, ON M5T 1W7, Canada.
Seyed Ali MirshahvaladToronto Joint Department Medical Imaging, University Health Network, Sinai Health System, Women's College Hospital, University Medical Imaging Toronto, Toronto, ON M5T 1W7, Canada.ORCID 0000-0003-2271-9764
Roshini KulanthaiveluToronto Joint Department Medical Imaging, University Health Network, Sinai Health System, Women's College Hospital, University Medical Imaging Toronto, Toronto, ON M5T 1W7, Canada.ORCID 0000-0002-2279-8346
Adam FaragToronto Joint Department Medical Imaging, University Health Network, Sinai Health System, Women's College Hospital, University Medical Imaging Toronto, Toronto, ON M5T 1W7, Canada.ORCID 0000-0002-8439-9498
Claudia OrtegaToronto Joint Department Medical Imaging, University Health Network, Sinai Health System, Women's College Hospital, University Medical Imaging Toronto, Toronto, ON M5T 1W7, Canada.
Ur MetserToronto Joint Department Medical Imaging, University Health Network, Sinai Health System, Women's College Hospital, University Medical Imaging Toronto, Toronto, ON M5T 1W7, Canada.ORCID 0000-0003-3726-8994
Patrick Veit-HaibachToronto Joint Department Medical Imaging, University Health Network, Sinai Health System, Women's College Hospital, University Medical Imaging Toronto, Toronto, ON M5T 1W7, Canada.
University Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To assess the impact of the COVID-19 pandemic on the diagnosis, staging and outcome of a selected population throughout the first two years of the pandemic, we evaluated oncology patients undergoing PET/CT at our institution. A retrospective population of lung cancer, melanoma, lymphoma and head and neck cancer patients staged using PET/CT during the first 6 months of the years 2019, 2020 and 2021 were included for analysis. The year in which the PET was performed was our exposure variable, and our two main outcomes were stage at the time of the PET/CT and overall survival (OS). A total of 1572 PET/CTs were performed for staging purposes during the first 6 months of 2019, 2020 and 2021. The median age was 66 (IQR 16), and 915 (58%) were males. The most prevalent staged cancer was lung cancer (643, 41%). The univariate analysis of staging at PET/CT and OS by year of PET/CT were not significantly different. The multivariate Cox regression of non-COVID-19 significantly different variables at univariate analysis and the year of PET/CT determined that lung cancer (HR 1.76 CI95 1.23-2.53,

Indexed as

cancerCOVID-19PET/CTstaging

Identifiers

PMID38001619
PMCPMC10670509
OpenAlexW4388570017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.